Fourth, diet therapy and exercise therapy are recommended when BMI begins to increase, and medications for hypercholesterolemia such as hydroxymethylglutaryl-coenzyme A reductase inhibitors and those for DM such as SGLT2 and insulin should be utilized for metabolic abnormalities. Here, SLC5A2 is linked to familial hypercholesterolemia.